Hemogenyx Pharmaceuticals Plc (HEMO.L)

GBp 320.0

(-8.57%)

Operating Expenses Summary of Hemogenyx Pharmaceuticals Plc

Hemogenyx Pharmaceuticals Plc's latest annual operating expenses in 2023 was 6.46 Million GBP , up 120.62% from previous year.
Hemogenyx Pharmaceuticals Plc's latest quarterly operating expenses in 2024 Q2 was 1345.57 GBP , down 0.0% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported a annual operating expenses of 2.93 Million GBP in annual operating expenses 2022, up 15.07% from previous year.
Hemogenyx Pharmaceuticals Plc reported a annual operating expenses of 2.54 Million GBP in annual operating expenses 2021, up 36.52% from previous year.
Hemogenyx Pharmaceuticals Plc reported a quarterly operating expenses of 1345.57 GBP for 2024 Q1, up 19.63% from previous quarter.
Hemogenyx Pharmaceuticals Plc reported a quarterly operating expenses of 1124.82 GBP for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Historical Annual Operating Expenses of Hemogenyx Pharmaceuticals Plc (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	6.46 Million GBP	120.62%
2022	2.93 Million GBP	15.07%
2021	2.54 Million GBP	36.52%
2020	1.86 Million GBP	49.33%
2019	1.24 Million GBP	-0.98%
2018	1.26 Million GBP	82.67%
2017	690.68 Thousand GBP	67.65%
2016	411.99 Thousand GBP	133.16%
2015	176.7 Thousand GBP	2718.21%
2014	6270.00 GBP	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	1345.57 GBP	0.0%
2024 Q1	1345.57 GBP	19.63%
2023 Q4	1124.82 GBP	0.0%
2023 FY	4.91 Million GBP	67.63%
2023 Q2	3.89 Million GBP	184724.88%
2023 Q3	1124.82 GBP	-99.97%
2023 Q1	2108.11 GBP	-99.91%
2022 Q2	1.11 Million GBP	194260.96%
2022 Q1	571.62 GBP	-99.96%
2022 Q4	2.32 Million GBP	162634.31%
2022 FY	2.93 Million GBP	15.07%
2022 Q3	1427.15 GBP	-99.87%
2021 Q3	1374.11 GBP	-99.88%
2021 Q2	1.09 Million GBP	221704.34%
2021 Q1	495.63 GBP	-99.96%
2021 Q4	1.47 Million GBP	107394.67%
2021 FY	2.54 Million GBP	36.52%
2020 Q1	409.66 GBP	-99.95%
2020 FY	1.86 Million GBP	49.33%
2020 Q3	622.91 GBP	-99.93%
2020 Q4	1.18 Million GBP	189750.4%
2020 Q2	861.03 Thousand GBP	210080.54%
2019 Q1	352.19 GBP	-25.21%
2019 Q4	829.8 Thousand GBP	216385.66%
2019 FY	1.24 Million GBP	-0.98%
2019 Q2	759.59 Thousand GBP	215576.02%
2019 Q3	383.31 GBP	-99.95%
2018 Q3	470.90 GBP	45.15%
2018 Q2	324.43 GBP	-0.0%
2018 Q1	324.43 GBP	-71.41%
2018 FY	1.26 Million GBP	82.67%
2018 Q4	470.90 GBP	0.0%
2017 Q4	1134.81 GBP	0.0%
2017 Q2	65.47 GBP	0.0%
2017 Q3	1134.81 GBP	1633.24%
2017 Q1	65.47 GBP	0.0%
2017 FY	690.68 Thousand GBP	67.65%
2016 Q4	- GBP	0.0%
2016 Q2	- GBP	0.0%
2016 FY	411.99 Thousand GBP	133.16%
2015 FY	176.7 Thousand GBP	2718.21%
2014 FY	6270.00 GBP	0.0%

Peer Operating Expenses Comparison of Hemogenyx Pharmaceuticals Plc

Name	Operating Expenses	Operating Expenses Difference